Peer Review reports
From: A phase 2 randomised controlled trial of serelaxin to lower portal pressure in cirrhosis (STOPP)
| Original Submission | ||
|---|---|---|
| 21 Aug 2019 | Submitted | Original manuscript |
| 9 Dec 2019 | Reviewed | Reviewer Report - Sandeep Gupta |
| 3 Jan 2020 | Reviewed | Reviewer Report - Mark Wielpütz |
| 29 Jan 2020 | Author responded | Author comments - Jonathan Fallowfield |
| 2 Feb 2020 | Reviewed | Reviewer Report - Sandeep Gupta |
| 3 Feb 2020 | Reviewed | Reviewer Report - Mark Wielpütz |
| 18 Feb 2020 | Reviewed | Reviewer Report - Riaz Qureshi |
| 20 Feb 2020 | Author responded | Author comments - Jonathan Fallowfield |
| Resubmission - Version 2 | ||
| 29 Jan 2020 | Submitted | Manuscript version 2 |
| 22 Feb 2020 | Reviewed | Reviewer Report - Riaz Qureshi |
| Resubmission - Version 3 | ||
| Submitted | Manuscript version 3 | |
| Publishing | ||
| 24 Feb 2020 | Editorially accepted | |
| 12 Mar 2020 | Article published | 10.1186/s13063-020-4203-9 |
You can find further information about peer review here.